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Background
Oesophageal cancer is responsible for 10,000 cancer
deaths in the United States and for 300,000 deaths in the
world each year.
Aim of this study is to evaluate the displacement rate of
EsophaCoil used in treatment of oesophageal cancer.
In our department we prefer to use nitinol self-expanding
stents (Esophacoil, Instent Inc., USA) for the radial force
that allow complete and rapid expansion even in the pres-
ence of thigh stenoses, the rapid relief of dysphagia,
adaptability of the spirals to the strictures with conse-
quently greater adhesion to the neoplasia and lower per-
centage of dislocations, the lower percentage of tumoural
ingrowth due to the serrated matching to the spirals.
Patients and methods
In our service from January 1995 to October 2002, 56 niti-
nol self-expanding stents (Esophacoil) were successfully
placed endoscopically in 54 patients. Indication of endo-
scopic treatment was unresectable oesophageal cancer in
all patients except one. The other patient was affected by
unresectable carcinoma of the bronchus. Procedures for
stent placement was: 1) Introduction of the endoscope
(Olympus GIF 100, GIF N30) to ascertain the diameter
and length of the stricture; 2) dilatation of tight stenoses
using Savary-Gilliard-Bougies (15-21-30 F); 3) reintroduc-
tion of the endoscope to beyond the stenosis and posi-
tioning of guide wire at the antral level; 4) identification
and marking with metallic strips on the skin, at the distal
and proximal ends of the stenosis; 5) sliding the delivery
catheter on the guide wire with the fluoroscopic localiza-
tion of the stent in correspondence to the stenosis; 6)
release of the retainers and removal of the catheter and the
guide wire; 7) endoscopic check of expended stent.
Results
In our series the percentage of dislocation of stent is quite
rare presenting only in four patients on 56 applications
made. These data (7.14%) are comparable to those
reported in literature (7.5%).
Conclusion
Self-expanding stents are the best choice in the treatment
of unresectable oesophageal cancer. EsophaCoil, has the
advantage of opening spontaneously, doesn’t need prob-
able multiple dilatation because its radial force allows
complete and rapid expansion even in the presence of
thigh stenoses with consequent rapid relief of dysphagia.
It also presented an elevated adaptability of the spirals to
the strictures with consequent greater adhesion to the
tumour, a lower percentage of dislocations and a lower
percentage of tumour ingrowths due to the serrated
matching to the spirals and an easy removal in case of
migration or malposition.
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